Postdoctoral researcher Ashleigh Shannon of University of Aix-Marseille presents, “Nucleoside analogues: Dual targeting of RdRp and NiRAN domains of SARS-CoV nsp12.”
Part of the NIBR Science of Therapeutics Symposium on Coronavirus Antivirals, June 8, 2021. Content presented by external speakers not affiliated with Novartis are responsible for their own content and do not speak on behalf of Novartis.
Learn more: https://bit.ly/3eUVnoa
©2021 Novartis AG
Source Novartis YouTube
